Chat with us
Also known as Femara
A non-steroidal aromatase inhibitor used as adjuvant treatment for hormone receptor-positive early breast cancer. Manufactured under GMP with full monograph compliance.
Enquiring about Letrozole · CAS 112809-51-5
NDAs signed within one business day. No sales spam — ever.
CAS 220127-57-1 · MW 589.7 g/mol
CAS 183319-69-9 · MW 429.9 g/mol